Published 16 October 2008, doi:10.1136/bmj.a2088
Cite this as: BMJ 2008;337:a2088

News

US psychiatrist steps down after questions about drug company payments

Janice Hopkins Tanne

1 New York

The first 150 words of the full text of this article appear below.

Charles Nemeroff, a US psychiatrist, has temporarily stepped down as chairman of the department of psychiatry and behavioural sciences at Emory University in Atlanta, Georgia, pending conclusions of investigations into alleged undisclosed payments from drug companies. He remains a professor at the university.

The US Senate Finance Committee has been looking into relations between drug companies and influential doctors and whether drug company funding has influenced the integrity of research and ultimately US doctors’ prescribing habits.

The committee’s investigation has found that Dr Nemeroff received funds from several drug companies but did not report them to his university, according to documents posted on the committee’s website (http://finance.senate.gov/sitepages/hearing091608.htm).

The university issued a statement last week saying, "Senator Charles Grassley (Republican, Iowa) [the leading Republican member on the finance committee] has raised a number of questions about whether Emory’s chairman of psychiatry and behavioural sciences, Dr Charles Nemeroff, has properly . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

US university psychiatrist loses chairmanship over drug company payments
Janice Hopkins Tanne
BMJ 2009 338: a3188. [Extract] [Full Text]

US psychiatrist is fired from radio programme for not disclosing drug company ties
Janice Hopkins Tanne
BMJ 2008 337: a2934. [Extract] [Full Text]

US senators inquire into ties between stent makers and doctors
Janice Hopkins Tanne
BMJ 2008 337: a2363. [Extract] [Full Text]

GlaxoSmithKline to limit payments it makes to US doctors to $150 000 a year
Zosia Kmietowicz
BMJ 2008 337: a2315. [Extract] [Full Text]

US university sets up conflict of interest office after investigation into drug company payments
Janice Hopkins Tanne
BMJ 2008 337: a2200. [Extract] [Full Text]




Access jobs at BMJ Careers
Whats new online at Student 

BMJ